rs2672583
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_002775.5(HTRA1):c.1005+169G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.291 in 152,042 control chromosomes in the GnomAD database, including 7,128 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.29 ( 7128 hom., cov: 32)
Consequence
HTRA1
NM_002775.5 intron
NM_002775.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.18
Publications
4 publications found
Genes affected
HTRA1 (HGNC:9476): (HtrA serine peptidase 1) This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]
HTRA1 Gene-Disease associations (from GenCC):
- CARASIL syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- genetic cerebral small vessel diseaseInheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
- HTRA1-related autosomal dominant cerebral small vessel diseaseInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 10-122507571-G-A is Benign according to our data. Variant chr10-122507571-G-A is described in ClinVar as Benign. ClinVar VariationId is 1296786.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HTRA1 | NM_002775.5 | c.1005+169G>A | intron_variant | Intron 5 of 8 | ENST00000368984.8 | NP_002766.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HTRA1 | ENST00000368984.8 | c.1005+169G>A | intron_variant | Intron 5 of 8 | 1 | NM_002775.5 | ENSP00000357980.3 | |||
| HTRA1 | ENST00000648167.1 | c.687+169G>A | intron_variant | Intron 5 of 8 | ENSP00000498033.1 | |||||
| HTRA1 | ENST00000420892.1 | c.228+169G>A | intron_variant | Intron 2 of 5 | 2 | ENSP00000412676.1 |
Frequencies
GnomAD3 genomes AF: 0.291 AC: 44263AN: 151926Hom.: 7119 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
44263
AN:
151926
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.291 AC: 44295AN: 152042Hom.: 7128 Cov.: 32 AF XY: 0.294 AC XY: 21822AN XY: 74328 show subpopulations
GnomAD4 genome
AF:
AC:
44295
AN:
152042
Hom.:
Cov.:
32
AF XY:
AC XY:
21822
AN XY:
74328
show subpopulations
African (AFR)
AF:
AC:
7116
AN:
41478
American (AMR)
AF:
AC:
6245
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
AC:
1020
AN:
3470
East Asian (EAS)
AF:
AC:
1984
AN:
5172
South Asian (SAS)
AF:
AC:
1443
AN:
4816
European-Finnish (FIN)
AF:
AC:
3403
AN:
10556
Middle Eastern (MID)
AF:
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22305
AN:
67982
Other (OTH)
AF:
AC:
621
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1568
3136
4704
6272
7840
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
444
888
1332
1776
2220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.